TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in <i>BRAF-</i> Mutant MelanomaRyan B. Corcoran, Jeffrey A. Engelman, Keith T. Flaherty et al.|Science Translational Medicine|2013Cited by 138